1. Home
  2. IOVA vs AVO Comparison

IOVA vs AVO Comparison

Compare IOVA & AVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • AVO
  • Stock Information
  • Founded
  • IOVA 2007
  • AVO 1983
  • Country
  • IOVA United States
  • AVO United States
  • Employees
  • IOVA N/A
  • AVO N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • AVO Farming/Seeds/Milling
  • Sector
  • IOVA Health Care
  • AVO Consumer Staples
  • Exchange
  • IOVA Nasdaq
  • AVO Nasdaq
  • Market Cap
  • IOVA 975.1M
  • AVO 836.8M
  • IPO Year
  • IOVA N/A
  • AVO 2020
  • Fundamental
  • Price
  • IOVA $2.68
  • AVO $12.24
  • Analyst Decision
  • IOVA Buy
  • AVO Strong Buy
  • Analyst Count
  • IOVA 10
  • AVO 2
  • Target Price
  • IOVA $12.22
  • AVO $15.50
  • AVG Volume (30 Days)
  • IOVA 26.0M
  • AVO 234.7K
  • Earning Date
  • IOVA 08-07-2025
  • AVO 09-08-2025
  • Dividend Yield
  • IOVA N/A
  • AVO N/A
  • EPS Growth
  • IOVA N/A
  • AVO 108.17
  • EPS
  • IOVA N/A
  • AVO 0.52
  • Revenue
  • IOVA $212,679,000.00
  • AVO $1,392,900,000.00
  • Revenue This Year
  • IOVA $86.62
  • AVO $8.85
  • Revenue Next Year
  • IOVA $69.13
  • AVO N/A
  • P/E Ratio
  • IOVA N/A
  • AVO $23.65
  • Revenue Growth
  • IOVA 11070.12
  • AVO 29.50
  • 52 Week Low
  • IOVA $1.64
  • AVO $9.56
  • 52 Week High
  • IOVA $12.51
  • AVO $15.25
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 53.63
  • AVO 55.14
  • Support Level
  • IOVA $1.70
  • AVO $12.12
  • Resistance Level
  • IOVA $4.33
  • AVO $12.50
  • Average True Range (ATR)
  • IOVA 0.40
  • AVO 0.25
  • MACD
  • IOVA -0.01
  • AVO -0.01
  • Stochastic Oscillator
  • IOVA 37.26
  • AVO 62.86

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About AVO Mission Produce Inc.

Mission Produce Inc is engaged in the business of producing and distributing avocados, serving retail, wholesale, and food service customers. Also, the company provides additional services like ripening, bagging, custom packing, and logistical management. The company's operating segments include Marketing and Distribution, International Farming and Blueberries. It generates maximum revenue from the Marketing and Distribution segment. The Marketing and Distribution segment sources fruit mainly from growers and then distributes fruit through a distribution network. Geographically distributed across North America, China, Europe, and the U.K.

Share on Social Networks: